3-氨基-4-(环丙基氨基)吡啶 | 146950-68-7

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 3-氨基-4-(环丙基氨基)吡啶
• 中文别名: (3-氨基-4-(环丙基氨基)吡啶)
• 英文名称: N⁴-cyclopropylpyridine-3,4-diamine
• 英文别名: N4-Cyclopropylpyridine-3,4-diamine；4-N-cyclopropylpyridine-3,4-diamine
• CAS: 146950-68-7
• 化学式: C₈H₁₁N₃
• 分子量: 149.195
• InChiKey: VPGWOWXXDKITFM-UHFFFAOYSA-N

物化性质

• 沸点：
  353.5±27.0 °C(Predicted)
• 密度：
  1.312±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  50.9
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  存储条件：2-8℃，干燥避光

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Amino-4-(cyclopropylamino)pyridine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Amino-4-(cyclopropylamino)pyridine
CAS number: 146950-68-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H11N3
Molecular weight: 149.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氨基-4-(环丙基氨基)吡啶 在 三乙烯二胺 、 偶氮二甲酸二异丙酯 、 三苯基膦 、 lithium hydroxide 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 1.25h， 生成 3-((5-chloro-1-(4-fluorobutyl)-1H-imidazo[4,5-b]pyridin-2-yl)methyl)-1-cyclopropyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one
  参考文献：
  名称：

  [EN] AZABENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
  [FR] AZABENZIMIDAZOLES EN TANT QU'AGENTS ANTIVIRAUX CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL

  摘要：

  一种满足以下公式I的化合物，包括前药、N-氧化物、加合盐、季铵金属配合物或其立体化学异构体形式；（公式I）组合物中包含这些化合物作为活性成分，以及制备这些化合物和组合物的方法。

  公开号：

  WO2012080449A1
• 作为产物：
  描述：

  N-环丙基-4-氨基-3-硝基吡啶 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙醇 为溶剂， 以95 %的产率得到3-氨基-4-(环丙基氨基)吡啶
  参考文献：
  名称：

  BIPHENYL DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF

  摘要：

  一种由一般式(Ib)表示的二苯基衍生物抑制剂，用于制备治疗癌症、传染病和自身免疫疾病的药物。

  公开号：

  EP4086253A1

文献信息

• 靶向人La蛋白的先导化合物及其在制备抗乙型 肝炎病毒的药物中的用途
  申请人：上海市第一人民医院

  公开号：CN103860538B

  公开（公告）日：2016-03-02

  本发明属制药领域，涉及靶向人La蛋白的先导化合物及其在制备抗乙型肝炎病毒的药物中的用途。本发明通过对靶标La蛋白增加HBV？RNA稳定性的研究，筛选得到式（Ⅰ）的靶向人La蛋白的先导化合物，经试验显示，所述的先导化合物具有较强的抗病毒活性，和具有靶向La蛋白的作用。本发明的先导化合物可进行进一步的结构优化，具有较好的应用前景；所述的先导化合物及其衍生物可用于制备抗乙型肝炎病毒的药物，也可用于制备以La蛋白为靶标的药物。
• [EN] INDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS<br/>[FR] INDOLES EN TANT QU'AGENTS ANTIVIRAUX CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL
  申请人：JANSSEN R & D IRELAND

  公开号：WO2012080447A1

  公开（公告）日：2012-06-21

  Indoles having inhibitory activity on RSV replication and having the formula I the prodrugs, N-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms thereof, compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.

  Indoles具有对RSV复制具有抑制活性的公式I的前药，N-氧化物，加成盐，季铵盐，金属配合物和立体化学异构体形式，含有这些化合物作为活性成分的组合物以及制备这些化合物和组合物的过程。
• [EN] PYRIDOPYRAZINONES DERIVATIVES INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES<br/>[FR] DÉRIVÉS DE PYRIDOPYRAZINONE COMME STIMULATEURS DE LA SÉCRÉTION D'INSULINE, LEURS PROCÉDÉS D'OBTENTION ET LEUR UTILISATION POUR LE TRAITEMENT DU DIABÈTE
  申请人：MERCK PATENT GMBH

  公开号：WO2009109341A1

  公开（公告）日：2009-09-11

  The present invention relates to pyridopyrazinone derivatives of formula (I), wherein X, Y, Z1 W, A and R1 are as defined in claim 1, as insulin secretion stimulators. The invention also relates to the preparation and use of these pyridopyrazinone derivatives for the prophylaxis and/or treatment of diabetes and pathologies associated.

  本发明涉及式(I)的吡啶吡嗪酮衍生物，其中X、Y、Z1、W、A和R1如权利要求1所定义，作为胰岛素分泌刺激剂。该发明还涉及制备和使用这些吡啶吡嗪酮衍生物用于糖尿病和相关病理预防和/或治疗。
• Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
  申请人：——

  公开号：US20030207868A1

  公开（公告）日：2003-11-06

  The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.

  本发明涉及抗病毒化合物，其制备方法及其组合物，以及在治疗病毒感染中的应用。更具体地，该发明提供了用于治疗呼吸道合胞病毒感染的杂环取代2-甲基苯并咪唑衍生物。
• [EN] QUINAZOLINE BASED RESPIRATORY SYNCYTIAL VIRUS INHIBITORS<br/>[FR] INHIBITEURS DU VIRUS SYNCYTIAL RESPIRATOIRE À BASE DE QUINAZOLINE
  申请人：MEDIVIR AB

  公开号：WO2015065338A1

  公开（公告）日：2015-05-07

  Compounds of Formula (I), wherein R1, R2, R3, R4 and n are defined herein, are useful as inhibitors of RSV.

  式（I）的化合物，其中R1、R2、R3、R4和n的定义如下，在RSV的抑制剂方面是有用的。